NCT06896279

Brief Summary

Investigating the efficacy and safety of temporal interference stimulation for patients with disorders of consciousness.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
0mo left

Started Apr 2025

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress98%
Apr 2025May 2026

First Submitted

Initial submission to the registry

March 3, 2025

Completed
23 days until next milestone

First Posted

Study publicly available on registry

March 26, 2025

Completed
26 days until next milestone

Study Start

First participant enrolled

April 21, 2025

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 16, 2026

Expected
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 17, 2026

Last Updated

December 16, 2025

Status Verified

March 1, 2025

Enrollment Period

1.1 years

First QC Date

March 3, 2025

Last Update Submit

December 8, 2025

Conditions

Keywords

Disorder of ConsciousnessRandomized clinical trailTemporal Interference Stimulation

Outcome Measures

Primary Outcomes (1)

  • Effective rate of awakening

    The CRS-R is employed, with a minimum of 5 CRS-R assessments conducted at each follow-up time point, accompanied by simultaneous video recording. And the highest value is scored as a state of consciousness. The clinical assessment of participants' consciousness is deemed significantly improved when it fulfills the following criteria: a) MCS- recover to consciousness level of MCS+ or higher; b) Vegetative state(VS) recover to consciousness level of MCS- or higher; c) MCS status (MCS- or MCS+) recover to emergence from MCS (restoration of functional communication).

    Stimulation for 1 month

Secondary Outcomes (7)

  • The difference of CRS-R scale relative to baseline between TI group and sham group

    Stimulation begin for 14 days, 1 month and 3 months

  • The difference of Simplified Evaluation of CONsciousness Disorders (SECONDs) scale relative to baseline between TI group and sham group

    Stimulation begin for 14 days, 1 month and 3 months

  • The difference of modified Ashworth scale relative to baseline between TI group and sham group

    Stimulation begin for 14 days, 1 month and 3 months

  • The difference of Nociception Coma Scale-Revised (NCS-R) scale relative to baseline between TI group and sham group

    Stimulation begin for 14 days, 1 month and 3 months

  • The difference of effective rate of awakening between TI group and sham group by CRS-R scale

    Stimulation begin for 1 month and 3 months

  • +2 more secondary outcomes

Study Arms (2)

TI stimulation group

EXPERIMENTAL

The two high-frequency electric fields of the TI device are set at different frequencies, thereby resulting in the generation of a low-frequency electric field that is capable of triggering brain physiological responses. The duration is 10 minutes.

Procedure: TI Stimulation

Sham TI stimulation group

SHAM COMPARATOR

The two high-frequency electric fields of the TI device are set to be completely of the same frequency (2000Hz), thus no low-frequency electric field is produced and no cerebral physiological responses are elicited. The duration lasts for 10 minutes.

Procedure: Sham Stimulation

Interventions

Participants will accept the TI stimulus for one month

TI stimulation group

Participants will accept the sham TI stimulus for one month

Sham TI stimulation group

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Severe consciousness disorder patients aged 18 to 75 years old, regardless of gender;
  • Patients with severe consciousness disorders, namely a minimally conscious state or vegetative state that lasts for 28 days or more;
  • Patients with normal body temperature, stable vital signs, spontaneous breathing, tracheotomy without the use of a metal cannula and with a small amount of sputum, and who are eligible for magnetic resonance imaging (MRI) examination;
  • Written informed consent obtained from the patient's family members in advance.

You may not qualify if:

  • Individuals with a previous history of significant neuropsychiatric and other major disorders such as those involving the heart, lung, liver, and kidney;
  • Those who have undergone V-P shunt or Ommaya reservoir implantation and other procedures that may influence the analysis of magnetic resonance scanning signals;
  • Patients who are scheduled for V-P shunt or Ommaya reservoir implantation in the near future;
  • Pregnant women;
  • Those who have participated in other drug or device clinical trials;
  • Patients with poorly controlled epilepsy in the recent period;
  • Those with infections at the TI stimulation site or compromised skin integrity at the electrode placement site;
  • Those currently taking medications prone to inducing epilepsy, such as quinolone drugs;
  • Those with intracranial infections, intracranial tumors, or metallic objects within the cranium;
  • Those allergic to electrode gel or adhesives;
  • Those with implanted electronic devices within the body;
  • Those with severe cardiac disorders and those equipped with cardiac pacemakers.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Department of neurological rehabilitation, Shanghai First Rehabilitation Hospital, Tongji University

Shanghai, Shanghai Municipality, 200000, China

RECRUITING

Department of Neurosurgery, Huashan Hospital, Fudan University

Shanghai, Shanghai Municipality, 200000, China

RECRUITING

Related Publications (6)

  • Violante IR, Alania K, Cassara AM, Neufeld E, Acerbo E, Carron R, Williamson A, Kurtin DL, Rhodes E, Hampshire A, Kuster N, Boyden ES, Pascual-Leone A, Grossman N. Non-invasive temporal interference electrical stimulation of the human hippocampus. Nat Neurosci. 2023 Nov;26(11):1994-2004. doi: 10.1038/s41593-023-01456-8. Epub 2023 Oct 19.

  • Thibaut A, Schiff N, Giacino J, Laureys S, Gosseries O. Therapeutic interventions in patients with prolonged disorders of consciousness. Lancet Neurol. 2019 Jun;18(6):600-614. doi: 10.1016/S1474-4422(19)30031-6. Epub 2019 Apr 16.

  • Giacino JT, Katz DI, Schiff ND, Whyte J, Ashman EJ, Ashwal S, Barbano R, Hammond FM, Laureys S, Ling GSF, Nakase-Richardson R, Seel RT, Yablon S, Getchius TSD, Gronseth GS, Armstrong MJ. Practice guideline update recommendations summary: Disorders of consciousness: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology; the American Congress of Rehabilitation Medicine; and the National Institute on Disability, Independent Living, and Rehabilitation Research. Neurology. 2018 Sep 4;91(10):450-460. doi: 10.1212/WNL.0000000000005926. Epub 2018 Aug 8.

  • Grossman N, Bono D, Dedic N, Kodandaramaiah SB, Rudenko A, Suk HJ, Cassara AM, Neufeld E, Kuster N, Tsai LH, Pascual-Leone A, Boyden ES. Noninvasive Deep Brain Stimulation via Temporally Interfering Electric Fields. Cell. 2017 Jun 1;169(6):1029-1041.e16. doi: 10.1016/j.cell.2017.05.024.

  • Tasserie J, Uhrig L, Sitt JD, Manasova D, Dupont M, Dehaene S, Jarraya B. Deep brain stimulation of the thalamus restores signatures of consciousness in a nonhuman primate model. Sci Adv. 2022 Mar 18;8(11):eabl5547. doi: 10.1126/sciadv.abl5547. Epub 2022 Mar 18.

  • Schiff ND. Recovery of consciousness after brain injury: a mesocircuit hypothesis. Trends Neurosci. 2010 Jan;33(1):1-9. doi: 10.1016/j.tins.2009.11.002. Epub 2009 Dec 1.

MeSH Terms

Conditions

Consciousness Disorders

Condition Hierarchy (Ancestors)

Neurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsNeurocognitive DisordersMental Disorders

Study Officials

  • Xuehai Wu, Ph.D.

    Department of Neurosurgery, Huashan Hospital, Fudan University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Wentao Huang, M.M.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
This study is being conducted as a double-blind trial, wherein the surgeons, assessors and participants' family members are kept unaware of the assigned research groups. However, it is necessary to inform the physicians responsible for adjustment of stimulation parameters about the allocation of participants. Follow-up assessments of participants after stimulation will be conducted by an independent assessor using standardized evaluation criteria.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Deputy Director of Shanghai Neurosurgical Emergency Center

Study Record Dates

First Submitted

March 3, 2025

First Posted

March 26, 2025

Study Start

April 21, 2025

Primary Completion (Estimated)

May 16, 2026

Study Completion (Estimated)

May 17, 2026

Last Updated

December 16, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations